Exane Derivatives’s iShares MSCI Canada ETF EWC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1
Closed -$27 645
2017
Q1
$27 Sell
1
-124
-99% -$3.35K ﹤0.01% 541
2016
Q4
$3.27K Sell
125
-656
-84% -$16.9K ﹤0.01% 445
2016
Q3
$20.1K Sell
781
-43
-5% -$1.09K ﹤0.01% 362
2016
Q2
$20.2K Buy
+824
New +$20.2K ﹤0.01% 331
2015
Q2
Sell
-10,719
Closed -$291K 533
2015
Q1
$291K Buy
10,719
+585
+6% +$16.1K 0.03% 177
2014
Q4
$292K Buy
+10,134
New +$298K 0.04% 183

Other funds holding EWC

Exane Derivatives's EWC Position: Q2 2017 in Review

Exane Derivatives sold out of iShares MSCI Canada ETF (EWC) in Q2 2017, closing a stake of 1 share — an estimated $27 sold.

Exane Derivatives first reported a position in EWC in Q4 2014 and held it in 6 quarters. The position peaked at $292K in Q4 2014. 219 funds tracked by Wall St. Rank hold EWC as of Q2 2017.

  • Exane Derivatives reported no remaining iShares MSCI Canada ETF position as of Q2 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 iShares MSCI Canada ETF share in Q2 2017, an estimated $27.
  • Exane Derivatives first reported a position in iShares MSCI Canada ETF in Q4 2014 and held it in 6 quarters.
  • Exane Derivatives's iShares MSCI Canada ETF position peaked at $292K in Q4 2014.
  • 219 funds tracked by Wall St. Rank held iShares MSCI Canada ETF as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.